review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1080/MMY.38.S1.225.236 |
P698 | PubMed publication ID | 11204149 |
P50 | author | Pierre Ambroise-Thomas | Q34020262 |
Josepa Gené | Q36590494 | ||
Josep Guarro Artigas | Q36591058 | ||
Delphine Aldebert | Q62757319 | ||
P2093 | author name string | D A Stevens | |
K V Clemons | |||
D C Coleman | |||
D J Sullivan | |||
J Pontón | |||
J Cano | |||
R Rüchel | |||
A J Carrillo-Muñoz | |||
R Grillot | |||
C Pinel | |||
P921 | main subject | emerging pathogen | Q108429945 |
P304 | page(s) | 225-236 | |
P577 | publication date | 2000-01-01 | |
P1433 | published in | Medical Mycology | Q6806389 |
P1476 | title | Emerging pathogens. | |
P478 | volume | 38 Suppl 1 |
Q36246196 | Activity of posaconazole in the treatment of central nervous system fungal infections |
Q34459194 | Benzothieno[3,2-b]quinolinium and 3-(phenylthio)quinolinium compounds: Synthesis and evaluation against opportunistic fungal pathogens. |
Q28547230 | Characterization of Cell Wall Proteins in Saccharomyces cerevisiae Clinical Isolates Elucidates Hsp150p in Virulence |
Q36011378 | Combination treatment of invasive fungal infections |
Q35224754 | Comparative genomic analysis reveals a critical role of de novo nucleotide biosynthesis for Saccharomyces cerevisiae virulence |
Q44630736 | Comparative virulence of Scedosporium species in animal models |
Q43011375 | Comparison of API20C with molecular identification of Candida spp isolated from bloodstream infections |
Q39051666 | Detection of Candida dubliniensis in Venezuela |
Q36933405 | Development and validation of a quantitative PCR assay for diagnosis of scedosporiosis. |
Q36026130 | Diagnosis of fusariosis in urine cytology |
Q44010897 | Differences in activation of MAP kinases and variability in the polyglutamine tract of Slt2 in clinical and non-clinical isolates of Saccharomyces cerevisiae |
Q34619767 | Disseminated Fusarium infection originating from paronychia in a neutropenic patient: a case report and review of the literature |
Q36277042 | Enrichment of multilocus sequence typing clade 1 with oral Candida albicans isolates in patients with untreated periodontitis |
Q42943910 | Epidemiology of fungaemia in a paediatric hospital of high complexity |
Q35073427 | Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species |
Q36047788 | Fungal Cell Wall Septation and Cytokinesis Are Inhibited by Bleomycins |
Q40634702 | Fusarium oxysporum as a multihost model for the genetic dissection of fungal virulence in plants and mammals |
Q35914298 | Genome sequencing and comparative analysis of Saccharomyces cerevisiae strain YJM789. |
Q44489725 | Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae |
Q35599856 | Glucocorticoids and invasive fungal infections |
Q44552191 | Glycosphingolipids of the model fungus Aspergillus nidulans: characterization of GIPCs with oligo-alpha-mannose-type glycans |
Q40644584 | HIV-1 and its transmembrane protein gp41 bind to different Candida species modulating adhesion |
Q42876579 | In Vitroactivity of conventional antifungal agents againstScedosporium apiospermumisolates recovered from clinical and environmental samples in Nigeria |
Q37734590 | In vitro activity of anidulafungin against selected clinically important mold isolates |
Q41355300 | In vitro inhibitory activities of magnolol against Candida spp. |
Q35622021 | Infections caused by Fusarium species |
Q43705836 | Issues in identifying germ tube positive yeasts by conventional methods. |
Q26746939 | Marine Sponges as a Drug Treasure |
Q37762556 | Mechanisms of antifungal drug resistance in Candida dubliniensis |
Q36452663 | Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans |
Q44458603 | Murine model of disseminated fusariosis: evaluation of the fungal burden by traditional CFU and quantitative PCR. |
Q35116244 | Newer antifungal therapy for emerging fungal pathogens |
Q34041713 | Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting |
Q43215984 | Occurrence of yeasts in psittacines droppings from captive birds in Italy |
Q28306629 | Polarisome meets spitzenkörper: microscopy, genetics, and genomics converge |
Q43883282 | Prevalence of Candida dubliniensis among cancer patients in Kuwait: a 5-year retrospective study |
Q44045225 | Prevalence of fungal infections detected from biopsies and autopsies in the past 11 years at the University Hospital Joan XXIII in Tarragona, Spain |
Q34455991 | Prospective evaluation of the new chromogenic medium Candida ID, in comparison with Candiselect, for isolation of molds and isolation and presumptive identification of yeast species |
Q39751370 | Racial Distribution of Candida dubliniensis Colonization among South Africans |
Q42708818 | Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression |
Q42582639 | Role of nitrogen and carbon transport, regulation, and metabolism genes for Saccharomyces cerevisiae survival in vivo |
Q42361178 | Saccharomyces cerevisiae show low levels of traversal across human endothelial barrier in vitro. |
Q35194598 | Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide |
Q35622016 | Scedosporium species infections and treatments |
Q31035863 | Synthetic combinatorial libraries as an alternative strategy for the development of novel treatments for infectious diseases |
Q35561978 | The 100-genomes strains, an S. cerevisiae resource that illuminates its natural phenotypic and genotypic variation and emergence as an opportunistic pathogen |
Q52860259 | The use of Niger seed agar to screen for Candida dubliniensis in the clinical microbiology laboratory |
Q41787399 | Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex |
Q34764156 | Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settings |
Q35825582 | Voriconazole, a novel wide‐spectrum triazole: oral pharmacokinetics and safety |
Q81533852 | [In vitro activity of the echinocandins. How should it be evaluated?] |
Search more.